AROVELLA THERAPEUTICS LTD

0.059

0.000

成交量：98.37萬

成交額：5.94萬

市值：7,131.82萬

市盈率：-10.17

高：0.062

開：0.062

低：0.059

收：0.059

52周最高：0.125

52周最低：0.058

股本：12.09億

流通股本：8.96億

量比：2.96

換手率：0.11%

股息：- -

股息率：- -

每股收益(TTM):-0.006

每股收益(LYR):-0.006

淨資產收益率：-40.41%

總資產收益率：-26.35%

市淨率：5.04

市盈率(LYR):-10.17

資料載入中...

總覽公司新聞資訊公告

概念

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

查爾斯河為Arovella Therapeutics提供NGS服務，加速推進替代性癌症療法研發

美股速递

·

07/13

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/ALA.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ALA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","market":"AU","secType":"STK","nameCN":"AROVELLA THERAPEUTICS LTD","latestPrice":0.059,"timestamp":1789539120000,"preClose":0.059,"halted":0,"volume":983701,"delay":0,"changeRate":0,"nameEN":"AROVELLA THERAPEUTICS LTD","floatShares":895858885,"shares":1208783672,"eps":-0.0058,"marketStatus":"已收盤","change":0,"latestTime":"09-16 16:12:00 AEST","open":0.062,"high":0.062,"low":0.059,"amount":59359,"amplitude":0.050847,"askPrice":0.061,"askSize":415374,"bidPrice":0.059,"bidSize":313279,"shortable":3,"etf":0,"ttmEps":-0.0058,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.059,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":2.964492,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ALA.AU","preClose":0.059,"auctionPrice":0.059,"auctionVolume":50000,"auctionTime":1789539004932,"referencePrice":0.059,"referenceTime":1789554603098,"auction":3,"marketStatus":"盘后竞价","timestamp":1789539004932}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","floatShares":895858885,"roa":"-26.35%","roe":"-40.41%","lyrEps":-0.0058,"volumeRatio":2.964492,"shares":1208783672,"dividePrice":0,"high":0.062,"amplitude":0.050847,"preClose":0.059,"low":0.059,"week52Low":0.058,"pbRate":"5.04","psRate":"20.39","week52High":0.125,"institutionHeld":0,"latestPrice":0.059,"committee":-0.140115,"eps":-0.0058,"divideRate":0,"volume":983701,"delay":0,"ttmEps":-0.0058,"open":0.062,"prevYearClose":0.093,"prevWeekClose":0.06,"prevMonthClose":0.06,"prevQuarterClose":0.062,"fiveDayClose":0.06,"twentyDayClose":0.063,"sixtyDayClose":0.068},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALA.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1169951164","title":"查爾斯河為Arovella Therapeutics提供NGS服務，加速推進替代性癌症療法研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1169951164","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169951164?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:04","pubTimestamp":1783944261,"startTime":"0","endTime":"0","summary":"查尔斯河实验室已向Arovella Therapeutics Ltd提供下一代测序服务，此举旨在加速开发创新的替代性癌症治疗方法。这项合作将利用查尔斯河在NGS技术方面的专业能力，支持Arovella Therapeutics推进其肿瘤治疗研发管线。通过提供关键的基因组学数据和分析服务，查尔斯河将帮助Arovella更深入地理解疾病机制，并加速潜在疗法的发现与优化进程。此次服务合作凸显了生物技术公司与专业研发服务提供商之间协同的重要性，共同致力于应对癌症治疗领域的复杂挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL","BK4121","LU0128526141.USD","IE00BFMHRM44.USD","LU1815336091.USD","BK4588","BK4530","LU0029874061.USD","LU0757428866.USD","LU0390134368.USD","ALA.AU","BK4585","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}